Back to companies
Silence Therapeutics plc
SLNGBNASDAQPharmaceuticals & HealthcareSilence Therapeutics plc
Revenue
$559,000
YoY -98.7%
Operating income
-$91.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API